Related Experiment Video
Updated: Jul 26, 2025

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Thrombin-activated interleukin-1α drives atherogenesis, but also promotes vascular smooth muscle cell proliferation
Laura C Burzynski1, Alejandra Morales-Maldonado1, Amanda Rodgers1
1Section of CardioRespiratory Medicine, The Heart and Lung Research Institute, The University of Cambridge, Papworth Road, Cambridge Biomedical Campus, Cambridge CB2 0BB, UK.
Insights
Ongoing coagulation contributes to atherosclerosis through thrombin activating interleukin-1 alpha (IL-1α). Targeting IL-1α or thrombin may offer therapeutic benefits for cardiovascular disease.
Area of Science:
- Cardiovascular Biology
- Immunology
- Hematology
Background:
- Atherosclerosis involves complex interactions between the immune and coagulation systems.
- The link between coagulation and immunity in atherogenesis, particularly via interleukin-1 alpha (IL-1α) activation by thrombin, is not fully understood.
Purpose of the Study:
- To investigate the role of thrombin-mediated IL-1α activation in atherosclerosis development.
- To characterize the impact of inhibiting this pathway on atherosclerotic plaque formation and stability.
Main Methods:
- Generated a novel knock-in mouse model (IL-1α thrombin mutant, IL-1αTM) unable to activate IL-1α via thrombin.
- Utilized Apoe-/- mice to study atherosclerotic plaque formation and composition.
- Employed bone marrow chimera experiments to determine the cellular origin of thrombin-activated IL-1α.
Main Results:
- IL-1αTM/Apoe-/- mice exhibited reduced atherosclerotic plaque formation and T-cell infiltration compared to controls.
- However, plaques in IL-1αTM/Apoe-/- mice showed decreased vascular smooth muscle cells, collagen, and fibrous caps, indicating increased instability.
- Thrombin inhibitors' anti-atherogenic effects were diminished in IL-1αTM/Apoe-/- mice, suggesting mediation through IL-1α.
- Thrombin-activated IL-1α originates from both vessel wall and myeloid cells.
Conclusions:
- The atherogenic effects of coagulation are partly mediated by thrombin cleavage of IL-1α.
- This highlights the crucial interplay between coagulation and immunity in atherosclerosis.
- Targeting IL-1α and/or thrombin presents potential therapeutic strategies.
- IL-1α may also influence atherosclerotic plaque stabilization.
Aims:
Atherosclerosis is driven by multiple processes across multiple body systems. For example, the innate immune system drives both atherogenesis and plaque rupture via inflammation, while coronary artery-occluding thrombi formed by the coagulation system cause myocardial infarction and death. However, the interplay between these systems during atherogenesis is understudied. We recently showed that coagulation and immunity are fundamentally linked by the activation of interleukin-1α (IL-1α) by thrombin, and generated a novel knock-in mouse in which thrombin cannot activate endogenous IL-1α [IL-1α thrombin mutant (IL-1αTM)].
Methods And Results:
Here, we show significantly reduced atherosclerotic plaque formation in IL-1αTM/Apoe-/- mice compared with Apoe-/- and reduced T-cell infiltration. However, IL-1αTM/Apoe-/- plaques have reduced vascular smooth muscle cells, collagen, and fibrous caps, indicative of a more unstable phenotype. Interestingly, the reduced atherogenesis seen with thrombin inhibition was absent in IL-1αTM/Apoe-/- mice, suggesting that thrombin inhibitors can affect atherosclerosis via reduced IL-1α activation. Finally, bone marrow chimeras show that thrombin-activated IL-1α is derived from both vessel wall and myeloid cells.
Conclusions:
Together, we reveal that the atherogenic effect of ongoing coagulation is, in part, mediated via thrombin cleavage of IL-1α. This not only highlights the importance of interplay between systems during disease and the potential for therapeutically targeting IL-1α and/or thrombin, but also forewarns that IL-1 may have a role in plaque stabilization.
Related Concept Videos
Atherosclerosis I: Introduction
Intracellular Signaling Affects Focal Adhesions
Some...
Clot Retraction and Fibrinolysis
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
TGF - β Signaling Pathway

